biotech

biotech

Lyme disease vaccine shows strong efficacy in phase 3 trial

biotech

FDA approves pill for plaque psoriasis

biotech

Crossbow Therapeutics raises $77m to treat cancer

biotech

Base to Base biotech podcast 52: Ketamine for depression, and a new company in the kidney disease space

biotech

Excalipoint Therapeutics launches with $68.7m to develop T-Cell engager therapies

biotech

FDA clearance for refractory gout treatment

biotech

Earendil Labs raises $787m to scale AI-driven biologics discovery and development

biotech

Researchers design drug capable of reversing cognitive decline in Alzheimer’s disease